Published in
Impact Journals, Oncotarget, 20(9), p. 15340-15349, 2018
DOI: 10.18632/oncotarget.24573
Links
Tools
Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience
Journal article published in 2018 by
Elisa De Carlo,
Maria Chiara Del Savio,
Jerry Polesel,
Valentina Da Ros,
Eleonora Berto,
Sandra Santarossa,
Emanuela Chimienti,
Lucia Fratino 
,
Alessandra Bearz
,
Alessandra Bearz
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 